1. Home
  2. SANW vs ONCT Comparison

SANW vs ONCT Comparison

Compare SANW & ONCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SANW
  • ONCT
  • Stock Information
  • Founded
  • SANW 1980
  • ONCT N/A
  • Country
  • SANW United States
  • ONCT United States
  • Employees
  • SANW N/A
  • ONCT N/A
  • Industry
  • SANW Farming/Seeds/Milling
  • ONCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • SANW Consumer Staples
  • ONCT Health Care
  • Exchange
  • SANW Nasdaq
  • ONCT Nasdaq
  • Market Cap
  • SANW 5.2M
  • ONCT 4.3M
  • IPO Year
  • SANW 2010
  • ONCT N/A
  • Fundamental
  • Price
  • SANW $2.23
  • ONCT $1.13
  • Analyst Decision
  • SANW
  • ONCT Buy
  • Analyst Count
  • SANW 0
  • ONCT 3
  • Target Price
  • SANW N/A
  • ONCT $10.00
  • AVG Volume (30 Days)
  • SANW 20.0K
  • ONCT 157.5K
  • Earning Date
  • SANW 11-19-2024
  • ONCT 11-06-2024
  • Dividend Yield
  • SANW N/A
  • ONCT N/A
  • EPS Growth
  • SANW N/A
  • ONCT N/A
  • EPS
  • SANW N/A
  • ONCT N/A
  • Revenue
  • SANW $60,441,646.00
  • ONCT $2,161,000.00
  • Revenue This Year
  • SANW $9.69
  • ONCT $113.76
  • Revenue Next Year
  • SANW $53.85
  • ONCT N/A
  • P/E Ratio
  • SANW N/A
  • ONCT N/A
  • Revenue Growth
  • SANW N/A
  • ONCT 227.92
  • 52 Week Low
  • SANW $2.10
  • ONCT $1.03
  • 52 Week High
  • SANW $14.25
  • ONCT $13.20
  • Technical
  • Relative Strength Index (RSI)
  • SANW 34.39
  • ONCT 37.09
  • Support Level
  • SANW $2.10
  • ONCT $1.03
  • Resistance Level
  • SANW $2.32
  • ONCT $1.30
  • Average True Range (ATR)
  • SANW 0.22
  • ONCT 0.19
  • MACD
  • SANW 0.05
  • ONCT -0.01
  • Stochastic Oscillator
  • SANW 17.81
  • ONCT 13.70

About SANW S&W Seed Company (NV)

S&W Seed Co is a multi-crop, middle-market agricultural company. It is engaged in the breeding, production, and sale of alfalfa seed and sorghum seed. It also has a growing commercial market presence in sunflower and maintains an active stevia development program. The company's seed platform develops and supplies germplasm designed to produce higher yields for farmers globally. It produces approximately 500 650 seed products and has a sale in more than 40 30 countries. Its geographical segments include the United States, Australia, Saudi Arabia, Mexico, South Africa, and other countries. Maximum of revenue is earned from USA following Australia second and Mexico third.

About ONCT Oncternal Therapeutics Inc.

Oncternal Therapeutics Inc is a clinical-stage oncology company developing first-in-class, novel therapies that target a broad spectrum of cancers with a large unmet medical need. The Company's clinical pipeline includes zilovertamab, a humanized monoclonal antibody that binds to ROR1 (Receptor-tyrosine kinase-like Orphan Receptor 1), and ONCT-216, a small molecule inhibiting the biological activity of ETS-family transcription factor oncoprotein. The Company is also developing ONCT-808, a CAR-T (chimeric antigen receptor T-cells) product candidate that target ROR1, and ONCT-534, a dual-action androgen receptor inhibitor product candidate for the treatment of castration-resistant prostate and other androgen receptor-driven cancers. The Company has one operating segment in the United States.

Share on Social Networks: